Previous studies reported that the expression levels of different CCT subunits are upregulated in various cancers, such as CCT8 and CCT3 in hepatocellular carcinoma18,22 or glioblastoma35, and CCT2 in prostate, breast, and lung cancers14,15,21. This evidence concerns the gene CCT2 and cancer.